Techsomed, a developer of image-guided therapy software, announced FDA 510(k) clearance of an expanded indication for the com ...

Techsomed received FDA 510(kclearance to expand indications for its BioTraceIO360 software platform to include percutaneous ...

(NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the acceptance of an oral presentation on results from the ...

BLACKFOOT —Bingham Healthcare is proud to announce that David Shelley MD, a leading vascular specialist, has successfully ...